Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fong, Y.
Right arrow Articles by Brennan, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fong, Y.
Right arrow Articles by Brennan, M. F.

Journal of Clinical Oncology, Vol 15, 938-946, Copyright © 1997 by American Society of Clinical Oncology

ARTICLES

Liver resection for colorectal metastases

Y Fong, AM Cohen, JG Fortner, WE Enker, AD Turnbull, DG Coit, AM Marrero, M Prasad, LH Blumgart and MF Brennan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. FongY@msKcc.org

PURPOSE: More than 50,000 patients in the United States will present each year with liver metastases from colorectal cancers. The current study was performed to determine if liver resection for colorectal metastases is safe and effective and to evaluate predictors of outcome. MATERIALS AND METHODS: Data for 456 consecutive resections performed between July 1985 and December 1991 in a tertiary referral center were analyzed. RESULTS: The perioperative mortality rate was 2.8%, with a mortality rate of 4.6% for resections that involved a lobectomy or more. The median hospital stay was 12 days and only 9% of patients were admitted to the intensive care unit. The 5-year survival rate is 38%, with a median survival duration of 46 months. By univariate analysis, nodal status of the primary lesion, short disease-free interval before detection of liver metastases, carcinoembryonic antigen (CEA) level greater than 200 ng/mL, multiple liver tumors, extrahepatic disease, large tumors, or positive resection margin was predictive of poorer outcome. Sex, age greater than 70 years, site of primary tumor, or perioperative transfusion was not predictive of outcome. By multivariate analysis, positive margin, size greater than 10 cm, disease-free interval less than 12 months, multiple tumors, and extrahepatic disease were independent predictors of poorer outcome. Short disease-free interval or multiple tumors were nevertheless associated with a 5-year survival rate greater than 24%. CONCLUSION: Liver resection for colorectal metastases is safe and effective therapy and currently represents the only potentially curative therapy for metastatic colorectal cancer. The only absolute contraindication to resection is extrahepatic disease. A randomized trial to examine efficacy of surgical resection cannot ethically be performed. Liver resection should be considered standard therapy for all fit patients with colorectal metastases isolated to the liver.


This article has been cited by other articles:


Home page
 RadiologyHome page
T. J. Vogl, N. N. N. Naguib, K. Eichler, T. Lehnert, H. Ackermann, and M. G. Mack
Volumetric Evaluation of Liver Metastases after Thermal Ablation: Long-term Results Following MR-guided Laser-induced Thermotherapy
Radiology, December 1, 2008; 249(3): 865 - 871.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. Mitry, A. L.A. Fields, H. Bleiberg, R. Labianca, G. Portier, D. Tu, D. Nitti, V. Torri, D. Elias, C. O'Callaghan, et al.
Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
J. Clin. Oncol., October 20, 2008; 26(30): 4906 - 4911.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. K. Salama, S. J. Chmura, N. Mehta, K. M. Yenice, W. M. Stadler, E. E. Vokes, D. J. Haraf, S. Hellman, and R. R. Weichselbaum
An Initial Report of a Radiation Dose-Escalation Trial in Patients with One to Five Sites of Metastatic Disease
Clin. Cancer Res., August 15, 2008; 14(16): 5255 - 5259.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. Adam, R. J. de Haas, D. A. Wicherts, T. A. Aloia, V. Delvart, D. Azoulay, H. Bismuth, and D. Castaing
Is Hepatic Resection Justified After Chemotherapy in Patients With Colorectal Liver Metastases and Lymph Node Involvement?
J. Clin. Oncol., August 1, 2008; 26(22): 3672 - 3680.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Ychou, D. Azria, C. Menkarios, P. Faurous, F. Quenet, B. Saint-Aubert, P. Rouanet, M. Pelegrin, C. Bascoul-Mollevi, D. Guerreau, et al.
Adjuvant Radioimmunotherapy Trial with Iodine-131-Labeled Anti-Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab')2 after Resection of Liver Metastases from Colorectal Cancer
Clin. Cancer Res., June 1, 2008; 14(11): 3487 - 3493.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. J. O'Connell, M. E. Campbell, R. M. Goldberg, A. Grothey, J.-F. Seitz, J. K. Benedetti, T. Andre, D. G. Haller, and D. J. Sargent
Survival Following Recurrence in Stage II and III Colon Cancer: Findings From the ACCENT Data Set
J. Clin. Oncol., May 10, 2008; 26(14): 2336 - 2341.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. Adam, D. A. Wicherts, R. J. de Haas, T. Aloia, F. Levi, B. Paule, C. Guettier, F. Kunstlinger, V. Delvart, D. Azoulay, et al.
Complete Pathologic Response After Preoperative Chemotherapy for Colorectal Liver Metastases: Myth or Reality?
J. Clin. Oncol., April 1, 2008; 26(10): 1635 - 1641.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. J. Bennett, C. R. Schmidt, D. S. Klimstra, S. R. Grobmyer, N. M. Ishill, M. D'Angelica, R. P. DeMatteo, Y. Fong, L. H. Blumgart, and W. R. Jarnagin
Perihepatic Lymph Node Micrometastases Impact Outcome after Partial Hepatectomy for Colorectal Metastases
Ann. Surg. Oncol., April 1, 2008; 15(4): 1130 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. Elias, S. Bonnet, C. Honore, N. Kohneh-Shahri, G. Tomasic, N. Lassau, C. Dromain, and D. Goere
Comparison Between the Minimum Margin Defined on Preoperative Imaging and the Final Surgical Margin After Hepatectomy for Cancer: How to Manage It?
Ann. Surg. Oncol., March 1, 2008; 15(3): 777 - 781.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. C. Posner, D. Niedzwiecki, A. P. Venook, D. R. Hollis, H. L. Kindler, E. W. Martin, R. L. Schilsky, R. M. Goldberg, and for the Cancer and Leukemia Group B
A Phase II Prospective Multi-institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903
Ann. Surg. Oncol., January 1, 2008; 15(1): 158 - 164.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
T. M. Pawlik, R. D. Schulick, and M. A. Choti
Expanding Criteria for Resectability of Colorectal Liver Metastases
Oncologist, January 1, 2008; 13(1): 51 - 64.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
P. V. Korita, T. Wakai, Y. Shirai, J. Sakata, K. Takizawa, P. V. Cruz, Y. Ajioka, and K. Hatakeyama
Intrahepatic Lymphatic Invasion Independently Predicts Poor Survival and Recurrences after Hepatectomy in Patients with Colorectal Carcinoma Liver Metastases
Ann. Surg. Oncol., December 1, 2007; 14(12): 3472 - 3480.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
D. J. Gallagher, M. Capanu, G. Raggio, and N. Kemeny
Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis
Ann. Onc., December 1, 2007; 18(12): 1995 - 1999.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
T. Liersch, J. Meller, M. Bittrich, B. Kulle, H. Becker, and D. M. Goldenberg
Update of Carcinoembryonic Antigen Radioimmunotherapy with 131I-Labetuzumab After Salvage Resection of Colorectal Liver Metastases: Comparison of Outcome to a Contemporaneous Control Group
Ann. Surg. Oncol., September 1, 2007; 14(9): 2577 - 2590.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
N. Kemeny
Presurgical Chemotherapy in Patients Being Considered for Liver Resection
Oncologist, July 1, 2007; 12(7): 825 - 839.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
A. Ahmad, S. L. Chen, and A. J. Bilchik
Role of Repeated Hepatectomy in the Multimodal Treatment of Hepatic Colorectal Metastases
Arch Surg, June 1, 2007; 142(6): 526 - 532.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. G. Mollevi, T. Serrano, M. M. Ginesta, J. Valls, J. Torras, M. Navarro, E. Ramos, J. R. Germa, E. Jaurrieta, V. Moreno, et al.
Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection
Carcinogenesis, June 1, 2007; 28(6): 1241 - 1246.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. Tanaka, H. Shimada, M. Ueda, K. Matsuo, I. Endo, and S. Togo
Long-Term Characteristics of 5-Year Survivors After Liver Resection for Colorectal Metastases
Ann. Surg. Oncol., April 1, 2007; 14(4): 1336 - 1346.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
M. Uehara, S. Yamamoto, S. Fujita, T. Akasu, Y. Moriya, and A. Morisue
Isolated Right External Iliac Lymph Node Recurrence from a Primary Cecum Carcinoma: Report of a Case
Jpn. J. Clin. Oncol., March 1, 2007; 37(3): 230 - 232.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
T. J. M. Ruers, J. J. Joosten, B. Wiering, B. S. Langenhoff, H. M. Dekker, T. Wobbes, W. J. G. Oyen, P. F. M. Krabbe, and C. J. A. Punt
Comparison Between Local Ablative Therapy and Chemotherapy for Non-Resectable Colorectal Liver Metastases: A Prospective Study
Ann. Surg. Oncol., March 1, 2007; 14(3): 1161 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
H. Korner, K. Soreide, P. J. Stokkeland, and J. A. Soreide
Diagnostic Accuracy of Serum-Carcinoembryonic Antigen in Recurrent Colorectal Cancer: A Receiver Operating Characteristic Curve Analysis
Ann. Surg. Oncol., February 1, 2007; 14(2): 417 - 423.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M.-S. Tsai, Y.-H. Su, M.-C. Ho, J.-T. Liang, T.-P. Chen, H.-S. Lai, and P.-H. Lee
Clinicopathological Features and Prognosis in Resectable Synchronous and Metachronous Colorectal Liver Metastasis
Ann. Surg. Oncol., February 1, 2007; 14(2): 786 - 794.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
B. Wiering, T. J. M. Ruers, P. F. M. Krabbe, H. M. Dekker, and W. J. G. Oyen
Comparison of Multiphase CT, FDG-PET and Intra-Operative Ultrasound in Patients with Colorectal Liver Metastases Selected for Surgery
Ann. Surg. Oncol., February 1, 2007; 14(2): 818 - 826.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. Ishiguro, T. Akasu, Y. Fujimoto, J. Yamamoto, Y. Sakamoto, T. Sano, K. Shimada, T. Kosuge, S. Yamamoto, S. Fujita, et al.
Second Hepatectomy for Recurrent Colorectal Liver Metastasis: Analysis of Preoperative Prognostic Factors
Ann. Surg. Oncol., December 1, 2006; 13(12): 1579 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
W. J. Fawcett and N. F. Quiney
Fluid Restriction and Major Surgery
Anesth. Analg., December 1, 2006; 103(6): 1608 - 1608.
[Full Text] [PDF]

Home page
 JCOHome page
C. C. Earle
Failing to Plan Is Planning to Fail: Improving the Quality of Care With Survivorship Care Plans
J. Clin. Oncol., November 10, 2006; 24(32): 5112 - 5116.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. R. Alberts
Evolving Role of Chemotherapy in Resected Liver Metastases
J. Clin. Oncol., November 1, 2006; 24(31): 4952 - 4953.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
Z. Z. R. Hamady, H. Z. Malik, R. Finch, R. Adair, A. Al-Mukhtar, K. R. Prasad, G. J. Toogood, and J. P. A. Lodge
Hepatic Resection for Colorectal Metastasis: Impact of Tumour Size
Ann. Surg. Oncol., November 1, 2006; 13(11): 1493 - 1499.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
O J Garden, M Rees, G J Poston, D Mirza, M Saunders, J Ledermann, J N Primrose, and R W Parks
Guidelines for resection of colorectal cancer liver metastases
Gut, August 1, 2006; 55(suppl_3): iii1 - iii8.
[Full Text] [PDF]

Home page
 JCOHome page
E. Van Cutsem
Progress With Biological Agents in Metastatic Colorectal Cancer Leads to Many Challenges
J. Clin. Oncol., July 20, 2006; 24(21): 3325 - 3327.
[Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
S. Takahashi, M. Konishi, T. Nakagohri, N. Gotohda, N. Saito, and T. Kinoshita
Short Time to Recurrence After Hepatic Resection Correlates with Poor Prognosis in Colorectal Hepatic Metastasis
Jpn. J. Clin. Oncol., June 1, 2006; 36(6): 368 - 375.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
F. H. van Duijnhoven, M. C. Jansen, J. M. C. Junggeburt, R. van Hillegersberg, A. M. Rijken, F. van Coevorden, J. R. van der Sijp, T. M. van Gulik, G. D. Slooter, J. M. Klaase, et al.
Factors Influencing the Local Failure Rate of Radiofrequency Ablation of Colorectal Liver Metastases
Ann. Surg. Oncol., May 1, 2006; 13(5): 651 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. S. Ong, M. Poirier, and N. J. Espat
Hepatic Intra-Arterial Chemotherapy
Ann. Surg. Oncol., February 1, 2006; 13(2): 142 - 149.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
G. Masi, S. Cupini, L. Marcucci, E. Cerri, F. Loupakis, G. Allegrini, I. M. Brunetti, E. Pfanner, M. Viti, O. Goletti, et al.
Treatment with 5-Fluorouracil/Folinic Acid, Oxaliplatin, and Irinotecan Enables Surgical Resection of Metastases in Patients With Initially Unresectable Metastatic Colorectal Cancer
Ann. Surg. Oncol., January 1, 2006; 13(1): 58 - 65.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
R. C. G. Martin II, S. A. McGuffin, L. M. Roetzer, T. D. Abell, and J. L. Studts
Method of Presenting Oncology Treatment Outcomes Influences Patient Treatment Decision-Making in Metastatic Colorectal Cancer
Ann. Surg. Oncol., January 1, 2006; 13(1): 86 - 95.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Chong and D. Cunningham
Improving Long-Term Outcomes for Patients With Liver Metastases From Colorectal Cancer
J. Clin. Oncol., December 20, 2005; 23(36): 9063 - 9066.
[Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
N. Dandachi, M. Balic, S. Stanzer, M. Halm, M. Resel, T. A. Hinterleitner, H. Samonigg, and T. Bauernhofer
Critical Evaluation of Real-Time Reverse Transcriptase-Polymerase Chain Reaction for the Quantitative Detection of Cytokeratin 20 mRNA in Colorectal Cancer Patients
J. Mol. Diagn., November 1, 2005; 7(5): 631 - 637.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. J. Poston, R. Adam, S. Alberts, S. Curley, J. Figueras, D. Haller, F. Kunstlinger, G. Mentha, B. Nordlinger, Y. Patt, et al.
OncoSurge: A Strategy for Improving Resectability With Curative Intent in Metastatic Colorectal Cancer
J. Clin. Oncol., October 1, 2005; 23(28): 7125 - 7134.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. Yedibela, J. Gohl, V. Graz, M. K. Pfaffenberger, S. Merkel, W. Hohenberger, and T. Meyer
Changes in Indication and Results After Resection of Hepatic Metastases From Noncolorectal Primary Tumors: A Single-Institutional Review
Ann. Surg. Oncol., October 1, 2005; 12(10): 778 - 785.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Kemeny, W. Jarnagin, P. Paty, M. Gonen, L. Schwartz, M. Morse, G. Leonard, M. D'Angelica, R. DeMatteo, L. Blumgart, et al.
Phase I Trial of Systemic Oxaliplatin Combination Chemotherapy With Hepatic Arterial Infusion in Patients With Unresectable Liver Metastases From Colorectal Cancer
J. Clin. Oncol., August 1, 2005; 23(22): 4888 - 4896.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
W. D. Ensminger
A Role for Hepatic-Directed Chemotherapy in Colorectal Liver Metastases
J. Clin. Oncol., August 1, 2005; 23(22): 4815 - 4817.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
D. V. Sahani, S. P. Kalva, A. J. Fischman, R. Kadavigere, M. Blake, P. F. Hahn, and S. Saini
Detection of Liver Metastases from Adenocarcinoma of the Colon and Pancreas: Comparison of Mangafodipir Trisodium-Enhanced Liver MRI and Whole-Body FDG PET
Am. J. Roentgenol., July 1, 2005; 185(1): 239 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C.J. Wray, A.M. Lowy, J.B. Mathews, S. Park, K.A. Choe, D.W. Hanto, L.E. James, D.A. Soldano, and S.A. Ahmad
The Significance and Clinical Factors Associated With a Subcentimeter Resection of Colorectal Liver Metastases
Ann. Surg. Oncol., May 1, 2005; 12(5): 374 - 380.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Domont, T. M. Pawlik, V. Boige, M. Rose, J.-C. Weber, P. M. Hoff, T. D. Brown, D. Zorzi, L. Morat, J.-P. Pignon, et al.
Catalytic Subunit of Human Telomerase Reverse Transcriptase Is an Independent Predictor of Survival in Patients Undergoing Curative Resection of Hepatic Colorectal Metastases: A Multicenter Analysis
J. Clin. Oncol., May 1, 2005; 23(13): 3086 - 3093.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. D. Leonard, B. Brenner, and N. E. Kemeny
Neoadjuvant Chemotherapy Before Liver Resection for Patients With Unresectable Liver Metastases From Colorectal Carcinoma
J. Clin. Oncol., March 20, 2005; 23(9): 2038 - 2048.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
T. Delaunoit, S. R. Alberts, D. J. Sargent, E. Green, R. M. Goldberg, J. Krook, C. Fuchs, R. K. Ramanathan, S. K. Williamson, R. F. Morton, et al.
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741
Ann. Onc., March 1, 2005; 16(3): 425 - 429.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Taieb, P. Artru, F. Paye, C. Louvet, N. Perez, T. Andre, B. Gayet, M. Hebbar, F. M. Goebel, C. Tournigand, et al.
Intensive Systemic Chemotherapy Combined With Surgery for Metastatic Colorectal Cancer: Results of a Phase II Study
J. Clin. Oncol., January 20, 2005; 23(3): 502 - 509.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
S. Sadahiro, T. Suzuki, K. Ishikawa, T. Nakamura, Y. Tanaka, K. Ishizu, S. Yasuda, H. Makuuchi, and C. Murayama
Estimation of the Time of Pulmonary Metastasis in Colorectal Cancer Patients with Isolated Synchronous Liver Metastasis
Jpn. J. Clin. Oncol., January 1, 2005; 35(1): 18 - 22.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
G. S. Gazelle, P. M. McMahon, M. T. Beinfeld, E. F. Halpern, and M. C. Weinstein
Metastatic Colorectal Carcinoma: Cost-effectiveness of Percutaneous Radiofrequency Ablation versus That of Hepatic Resection
Radiology, December 1, 2004; 233(3): 729 - 739.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
R. Haddad, R. T. Ogilvie, M. Croitoru, V. Muniz, R. Gryfe, A. Pollet, P. Shanmugathasan, T. Fitzgerald, C. H. L. Law, S. S. Hanna, et al.
Microsatellite Instability as a Prognostic Factor in Resected Colorectal Cancer Liver Metastases
Ann. Surg. Oncol., November 1, 2004; 11(11): 977 - 982.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
C. D. Mann, M. S. Metcalfe, L. N. Leopardi, and G. J. Maddern
The Clinical Risk Score: Emerging as a Reliable Preoperative Prognostic Index in Hepatectomy for Colorectal Metastases
Arch Surg, November 1, 2004; 139(11): 1168 - 1172.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
A R Gillams
Liver ablation therapy
Br. J. Radiol., September 1, 2004; 77(921): 713 - 723.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S.M. M. de Castro, E.H. B. M. Tilleman, O.R. C. Busch, O.M. van Delden, J.S. Lameris, T.M. van Gulik, H. Obertop, and D.J. Gouma
Diagnostic Laparoscopy for Primary and Secondary Liver Malignancies: Impact of Improved Imaging and Changed Criteria for Resection
Ann. Surg. Oncol., May 1, 2004; 11(5): 522 - 529.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. J. Bilchik and S. R. Martinez
Editorial: Novel Effective Drugs and Evolving Ablation Technology: A More Comprehensive Approach to Hepatic Malignancies
Ann. Surg. Oncol., May 1, 2004; 11(5): 458 - 459.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
W.-L. Yang, D. G. Nair, R. Makizumi, G. Gallos, X. Ye, R. R. Sharma, and T.S. Ravikumar
Heat Shock Protein 70 Is Induced in Mouse Human Colon Tumor Xenografts After Sublethal Radiofrequency Ablation
Ann. Surg. Oncol., April 1, 2004; 11(4): 399 - 406.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. Elias, L. Sideris, M. Pocard, J.-F. Ouellet, V. Boige, P. Lasser, J.-P. Pignon, and M. Ducreux
Results of R0 Resection for Colorectal Liver Metastases Associated With Extrahepatic Disease
Ann. Surg. Oncol., March 1, 2004; 11(3): 274 - 280.
[Abstract] [Full Text] [PDF]